Efficacy, tolerability and safety in the treatment of chronic hepatitis C with combination of PEG-Interferon – Ribavirin in daily practice

Efficacy, tolerability and safety in the treatment of chronic hepatitis C with combination of PEG-Interferon – Ribavirin in daily practice

Background. Efficacy and safety of Pegylated Interferon alfa (PegIFN)-Ribavirin (RBV) for the treatment of chronic hepatitis C (CHC) in routine clinical practice seems to be comparable with results of randomizedcontrolled trials.Aims. To evaluate the efficacy, tolerability and safety of CHC treatmen...

Full description

Bibliographic Details
Main Authors: Ezequiel Ridruejo, MD., Raúl Adrover, Daniel Cocozzella, Nora Fernández, María Virginia Reggiardo
Format: Article
Language:English
Published: Elsevier 2010-01-01
Series:Annals of Hepatology
Subjects:
Daily practice
HCV
Pegylated Interferon alfa
Ribavirin
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119316783

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119316783

Similar Items